title: Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling.
abstract: OBJECTIVE
  To review the evidence for the effectiveness of different isolation policies and screening practices in reducing the incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonisation and infection in hospital in-patients. To develop transmission models to study the effectiveness and cost-effectiveness of isolation policies in controlling MRSA.
  
  
  METHODS
  MEDLINE, EMBASE, CINAHL, The Cochrane Library and SIGLE (1966-2000). Hand-searching key journals. No language restrictions.
  
  
  METHODS
  Key data were extracted from articles reporting MRSA-related outcomes and describing an isolation policy in a hospital with epidemic or endemic MRSA. No quality restrictions were imposed on studies using isolation wards (IW) or nurse cohorting (NC). Other studies were included if they were prospective or employed planned comparisons of retrospective data. Stochastic and deterministic models investigated long-term transmission dynamics, studying the effect of a fixed capacity IW, producing economic evaluations using local cost data.
  
  
  RESULTS
  A total of 46 studies were accepted: 18 IWs, 9 NC, 19 other isolation policies. Most were interrupted time series, with few planned formal prospective studies. All but one reported multiple interventions. Consideration of potential confounders, measures to prevent bias, and appropriate statistical analysis were mostly lacking. No conclusions could be drawn in a third of studies. Most others provided evidence consistent with reduction of MRSA acquisition. Six long interrupted time series provided the strongest evidence. Four of these provided evidence that intensive control measures which included patient isolation were effective in controlling MRSA. In two others IW use failed to prevent endemic MRSA. There was no robust economic evaluation. Models showed that improving the detection rate or ensuring adequate isolation capacity reduced endemic levels, with substantial savings achievable.
  
  
  CONCLUSIONS
  Major methodological weaknesses and inadequate reporting in published research mean that many plausible alternative explanations for reductions in MRSA acquisition associated with interventions cannot be excluded. No well-designed studies allow the role of isolation measures alone to be assessed. Nonetheless, there is evidence that concerted efforts that include isolation can reduce MRSA even when endemic. Little evidence was found to suggest that current isolation measures recommended in the UK are ineffective, and these should continue to be applied until further research establishes otherwise. The studies with the strongest evidence, together with the results of the modelling, provide testable hypotheses for future research. Guidelines to facilitate design of future research are produced.
authors.affiliation: Academic Department of Geriatric Medicine, Royal Free Campus, Royal Free and University College Medical School, University of London, London, UK.
authors.forename: B S
authors.initials: BS
authors.lastname: Cooper
authors.forename: S P
authors.initials: SP
authors.lastname: Stone
authors.forename: C C
authors.initials: CC
authors.lastname: Kibbler
authors.forename: B D
authors.initials: BD
authors.lastname: Cookson
authors.forename: J A
authors.initials: JA
authors.lastname: Roberts
authors.forename: G F
authors.initials: GF
authors.lastname: Medley
authors.forename: G J
authors.initials: GJ
authors.lastname: Duckworth
authors.forename: R
authors.initials: R
authors.lastname: Lai
authors.forename: S
authors.initials: S
authors.lastname: Ebrahim
mesh_terms: D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D006302:Health Services Research; D006739:Hospital Administration / Q000592:standards*; D006801:Humans; D016106:Methicillin Resistance; D017059:Models, Econometric; D016134:Organizational Policy; D017063:Outcome Assessment, Health Care; D010356:Patient Isolation / Q000191:economics / Q000592:standards*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D013211:Staphylococcus aureus; D006113:United Kingdom / Q000453:epidemiology